Interviews: Hemispherx Biopharma, Inc. (NYSE Amex: HEB)
 |
Hemispherx Biopharma, Inc., a biopharmaceutical company, engages in the clinical development, manufacture, marketing, and distribution of drugs for the treatment of viral and immune-based chronic disorders. | |
| Symbol: HEB | Exchange: NYSE Amex | |
| Industry: Biotechnology | Web Site: www.hemispherx.net | |
| Interview | Date Published | Click the start button underneath to listen to the interview | ||
|---|---|---|---|---|
 |
Dr. William Carter Chairman and CEO |
Update 2 | 04-28-2009 |
|
| Update 1 | 02-22-2009 |
|
||
| Initial | 01-29-2009 |
|